Free Trial

ARM (ARM) Financials

ARM logo
$131.04 -1.01 (-0.76%)
As of 05/20/2025 04:00 PM Eastern
Annual Income Statements for ARM

Annual Income Statements for ARM

This table shows ARM's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 3/31/2024 3/31/2023 3/31/2022
Net Income / (Loss) Attributable to Common Shareholders
306 524 549
Consolidated Net Income / (Loss)
306 524 549
Net Income / (Loss) Continuing Operations
306 524 676
Total Pre-Tax Income
212 671 786
Total Operating Income
111 671 633
Total Gross Profit
3,079 2,573 2,572
Total Revenue
3,233 2,679 2,703
Operating Revenue
3,233 2,679 2,703
Total Cost of Revenue
154 106 131
Operating Cost of Revenue
154 106 131
Total Operating Expenses
2,968 1,902 1,939
Selling, General & Admin Expense
983 762 897
Research & Development Expense
1,979 1,133 995
Impairment Charge
0.00 0.00 21
Restructuring Charge
6.00 7.00 26
Total Other Income / (Expense), net
101 0.00 153
Interest & Investment Income
90 -3.00 143
Other Income / (Expense), net
11 3.00 10
Income Tax Expense
-94 147 110
Net Income / (Loss) Discontinued Operations
0.00 0.00 -127
Basic Earnings per Share
$0.30 $0.51 $0.54
Weighted Average Basic Shares Outstanding
1.03B 1.03B 1.03B
Diluted Earnings per Share
$0.29 $0.51 $0.54
Weighted Average Diluted Shares Outstanding
1.04B 1.03B 1.03B
Weighted Average Basic & Diluted Shares Outstanding
1.04B - -

Quarterly Income Statements for ARM

No quarterly income statements for ARM are available.


Annual Cash Flow Statements for ARM

This table details how cash moves in and out of ARM's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 3/31/2024 3/31/2023 3/31/2022
Net Change in Cash & Equivalents
369 550 -210
Net Cash From Operating Activities
1,090 739 458
Net Cash From Continuing Operating Activities
1,090 739 458
Net Income / (Loss) Continuing Operations
306 524 549
Consolidated Net Income / (Loss)
306 524 549
Depreciation Expense
162 170 185
Non-Cash Adjustments To Reconcile Net Income
755 92 -229
Changes in Operating Assets and Liabilities, net
-133 -47 -47
Net Cash From Investing Activities
-516 -138 -619
Net Cash From Continuing Investing Activities
-516 -138 -619
Purchase of Property, Plant & Equipment
-92 -64 -34
Acquisitions
-51 -29 -41
Purchase of Investments
-797 -1,126 -758
Sale and/or Maturity of Investments
425 1,081 245
Other Investing Activities, net
-1.00 0.00 -31
Net Cash From Financing Activities
-208 -42 -32
Net Cash From Continuing Financing Activities
-208 -42 -32
Repayment of Debt
-10 -2.00 -2.00
Payment of Dividends
0.00 0.00 -43
Issuance of Debt
0.00 0.00 50
Other Financing Activities, net
-198 -40 -37
Effect of Exchange Rate Changes
3.00 -9.00 -17
Cash Interest Paid
0.00 0.00 1.00
Cash Income Taxes Paid
188 159 141

Quarterly Cash Flow Statements for ARM

No quarterly cash flow statements for ARM are available.


Annual Balance Sheets for ARM

This table presents ARM's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023
Period end date 3/31/2024 3/31/2023
Total Assets
7,927 6,866
Total Current Assets
4,197 3,537
Cash & Equivalents
1,923 1,554
Short-Term Investments
1,000 661
Accounts Receivable
781 999
Prepaid Expenses
157 169
Other Current Assets
336 154
Plant, Property, & Equipment, net
215 185
Total Noncurrent Assets
3,515 3,144
Long-Term Investments
741 723
Noncurrent Note & Lease Receivables
240 -
Goodwill
1,625 1,620
Intangible Assets
152 138
Noncurrent Deferred & Refundable Income Taxes
282 139
Other Noncurrent Operating Assets
475 524
Total Liabilities & Shareholders' Equity
7,927 6,866
Total Liabilities
2,632 2,815
Total Current Liabilities
1,505 1,363
Current Deferred Revenue
198 293
Current Deferred & Payable Income Tax Liabilities
147 162
Current Employee Benefit Liabilities
298 589
Other Current Liabilities
862 319
Total Noncurrent Liabilities
1,107 1,452
Noncurrent Deferred Revenue
717 -
Noncurrent Deferred & Payable Income Tax Liabilities
135 262
Other Noncurrent Operating Liabilities
255 1,190
Commitments & Contingencies
0.00 0.00
Total Equity & Noncontrolling Interests
5,295 4,051
Total Preferred & Common Equity
5,295 4,051
Total Common Equity
5,295 4,051
Common Stock
2,173 1,218
Retained Earnings
2,751 2,457
Accumulated Other Comprehensive Income / (Loss)
371 376

Quarterly Balance Sheets for ARM

This table presents ARM's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q4 2023
Period end date 3/31/2024 3/31/2023
Total Assets
7,927 6,866
Total Current Assets
4,197 3,537
Cash & Equivalents
1,923 1,554
Short-Term Investments
1,000 661
Accounts Receivable
781 999
Prepaid Expenses
157 169
Other Current Assets
336 154
Plant, Property, & Equipment, net
215 185
Total Noncurrent Assets
3,515 3,144
Long-Term Investments
741 723
Noncurrent Note & Lease Receivables
240 -
Goodwill
1,625 1,620
Intangible Assets
152 138
Noncurrent Deferred & Refundable Income Taxes
282 139
Other Noncurrent Operating Assets
475 524
Total Liabilities & Shareholders' Equity
7,927 6,866
Total Liabilities
2,632 2,815
Total Current Liabilities
1,505 1,363
Current Deferred Revenue
198 293
Current Deferred & Payable Income Tax Liabilities
147 162
Current Employee Benefit Liabilities
298 589
Other Current Liabilities
862 319
Total Noncurrent Liabilities
1,107 1,452
Noncurrent Deferred Revenue
717 -
Noncurrent Deferred & Payable Income Tax Liabilities
135 262
Other Noncurrent Operating Liabilities
255 1,190
Commitments & Contingencies
0.00 0.00
Total Equity & Noncontrolling Interests
5,295 4,051
Total Preferred & Common Equity
5,295 4,051
Total Common Equity
5,295 4,051
Common Stock
2,173 1,218
Retained Earnings
2,751 2,457
Accumulated Other Comprehensive Income / (Loss)
371 376

Annual Metrics And Ratios for ARM

This table displays calculated financial ratios and metrics derived from ARM's official financial filings.

Metric 2024 2023 2022
Period end date 3/31/2024 3/31/2023 3/31/2022
Growth Metrics
- - -
Revenue Growth
20.68% -0.89% 0.00%
EBITDA Growth
-66.35% 1.93% 0.00%
EBIT Growth
-81.90% 4.82% 0.00%
NOPAT Growth
-69.46% -3.76% 0.00%
Net Income Growth
-41.60% -4.55% 0.00%
EPS Growth
-43.14% -5.56% 0.00%
Operating Cash Flow Growth
47.50% 61.35% 0.00%
Free Cash Flow Firm Growth
35.82% 0.00% 0.00%
Invested Capital Growth
48.34% 0.00% 0.00%
Revenue Q/Q Growth
0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00%
Profitability Metrics
- - -
Gross Margin
95.24% 96.04% 95.15%
EBITDA Margin
8.78% 31.50% 30.63%
Operating Margin
3.43% 25.05% 23.42%
EBIT Margin
3.77% 25.16% 23.79%
Profit (Net Income) Margin
9.46% 19.56% 20.31%
Tax Burden Percent
144.34% 78.09% 69.85%
Interest Burden Percent
173.77% 99.55% 122.24%
Effective Tax Rate
-44.25% 21.88% 13.96%
Return on Invested Capital (ROIC)
11.59% 94.20% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
7.15% 94.21% 0.00%
Return on Net Nonoperating Assets (RNNOA)
-5.04% -68.33% 0.00%
Return on Equity (ROE)
6.55% 25.87% 0.00%
Cash Return on Invested Capital (CROIC)
-27.34% -105.80% 0.00%
Operating Return on Assets (OROA)
1.65% 9.82% 0.00%
Return on Assets (ROA)
4.14% 7.63% 0.00%
Return on Common Equity (ROCE)
6.55% 25.87% 0.00%
Return on Equity Simple (ROE_SIMPLE)
5.78% 12.94% 0.00%
Net Operating Profit after Tax (NOPAT)
160 524 545
NOPAT Margin
4.95% 19.57% 20.15%
Net Nonoperating Expense Percent (NNEP)
4.43% -0.01% 0.00%
Cost of Revenue to Revenue
4.76% 3.96% 4.85%
SG&A Expenses to Revenue
30.41% 28.44% 33.19%
R&D to Revenue
61.21% 42.29% 36.81%
Operating Expenses to Revenue
91.80% 71.00% 71.74%
Earnings before Interest and Taxes (EBIT)
122 674 643
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
284 844 828
Valuation Ratios
- - -
Price to Book Value (P/BV)
24.66 1.20 0.00
Price to Tangible Book Value (P/TBV)
37.11 2.12 0.00
Price to Revenue (P/Rev)
40.38 1.82 1.80
Price to Earnings (P/E)
426.64 9.29 8.87
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
0.23% 10.76% 11.27%
Enterprise Value to Invested Capital (EV/IC)
76.86 1.74 0.00
Enterprise Value to Revenue (EV/Rev)
39.25 0.72 0.00
Enterprise Value to EBITDA (EV/EBITDA)
446.79 2.29 0.00
Enterprise Value to EBIT (EV/EBIT)
1,040.06 2.87 0.00
Enterprise Value to NOPAT (EV/NOPAT)
792.49 3.69 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
116.41 2.62 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00
Leverage & Solvency
- - -
Debt to Equity
0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00
Financial Leverage
-0.70 -0.73 0.00
Leverage Ratio
1.58 1.69 0.00
Compound Leverage Factor
2.75 1.69 0.00
Debt to Total Capital
0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 0.00%
Debt to EBITDA
0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00
Altman Z-Score
31.11 2.63 0.00
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00%
Liquidity Ratios
- - -
Current Ratio
2.79 2.60 0.00
Quick Ratio
2.46 2.36 0.00
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
-378 -589 0.00
Operating Cash Flow to CapEx
1,184.78% 1,154.69% 1,347.06%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00
Efficiency Ratios
- - -
Asset Turnover
0.44 0.39 0.00
Accounts Receivable Turnover
3.63 2.68 0.00
Inventory Turnover
0.00 0.00 0.00
Fixed Asset Turnover
16.17 14.48 0.00
Accounts Payable Turnover
0.00 0.00 0.00
Days Sales Outstanding (DSO)
100.48 136.11 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00
Cash Conversion Cycle (CCC)
100.48 136.11 0.00
Capital & Investment Metrics
- - -
Invested Capital
1,651 1,113 0.00
Invested Capital Turnover
2.34 4.81 0.00
Increase / (Decrease) in Invested Capital
538 1,113 0.00
Enterprise Value (EV)
126,888 1,933 0.00
Market Capitalization
130,552 4,871 4,871
Book Value per Share
$5.15 $3.95 $0.00
Tangible Book Value per Share
$3.42 $2.24 $0.00
Total Capital
5,295 4,051 0.00
Total Debt
0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00
Net Debt
-3,664 -2,938 0.00
Capital Expenditures (CapEx)
92 64 34
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-231 -41 0.00
Debt-free Net Working Capital (DFNWC)
2,692 2,174 0.00
Net Working Capital (NWC)
2,692 2,174 0.00
Net Nonoperating Expense (NNE)
-146 0.20 -4.35
Net Nonoperating Obligations (NNO)
-3,644 -2,938 0.00
Total Depreciation and Amortization (D&A)
162 170 185
Debt-free, Cash-free Net Working Capital to Revenue
-7.15% -1.53% 0.00%
Debt-free Net Working Capital to Revenue
83.27% 81.15% 0.00%
Net Working Capital to Revenue
83.27% 81.15% 0.00%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
$0.30 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
1.03B 0.00 0.00
Adjusted Diluted Earnings per Share
$0.29 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
1.04B 0.00 0.00
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.04B 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
82 530 585
Normalized NOPAT Margin
2.53% 19.77% 21.65%
Pre Tax Income Margin
6.56% 25.05% 29.08%
Debt Service Ratios
- - -
EBIT to Interest Expense
0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00
Payout Ratios
- - -
Dividend Payout Ratio
0.00% 0.00% 7.83%
Augmented Payout Ratio
0.00% 0.00% 7.83%

Quarterly Metrics And Ratios for ARM

No quarterly metrics and ratios for ARM are available.


Frequently Asked Questions About ARM's Financials

When does ARM's financial year end?

According to the most recent income statement we have on file, ARM's fiscal year ends in March. Their fiscal year 2024 ended on March 31, 2024.

How has ARM's net income changed over the last 2 years?

ARM's net income appears to be on a downward trend, with a most recent value of $306 million in 2024, falling from $549 million in 2022. The previous period was $524 million in 2023. See where experts think ARM is headed by visiting ARM's forecast page.

What is ARM's operating income?
ARM's total operating income in 2024 was $111 million, based on the following breakdown:
  • Total Gross Profit: $3.08 billion
  • Total Operating Expenses: $2.97 billion
How has ARM revenue changed over the last 2 years?

Over the last 2 years, ARM's total revenue changed from $2.70 billion in 2022 to $3.23 billion in 2024, a change of 19.6%.

How much debt does ARM have?

ARM's total liabilities were at $2.63 billion at the end of 2024, a 6.5% decrease from 2023, and a 6.5% decrease since 2023.

How much cash does ARM have?

In the past 1 years, ARM's cash and equivalents has ranged from $1.55 billion in 2023 to $1.92 billion in 2024, and is currently $1.92 billion as of their latest financial filing in 2024.

How has ARM's book value per share changed over the last 2 years?

Over the last 2 years, ARM's book value per share changed from 0.00 in 2022 to 5.15 in 2024, a change of 515.4%.



This page (NASDAQ:ARM) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners